chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Currently having it. I have a swollen face. Blurry vision. Difficulty standing. Shallow breaths. Headache. Chills. Body aches. 101 fever. Unable to sleep but very tired. Not able to breather through nose. Sore and numb right arm. Tingling of my limbs. Occasionally sharp pain in muscles. I got the shot at 11 and was just fine but I had work. I drove for a little over an hour and progressively my arm got weaker. I did physical labor until 10 pm and then started some school work, but found my arm almost unable to move and my mood was deteriorating. When I went to bed and lied down, it hit me. It is 4 am and it is still going strong.
Patient had puncture from bob wire; received Td immunization only 8/19/05 at about 1:30 PM. At 7:30 PM, became diaphoretic, nausea and vomiting one time. Then syncope with incontinence of bowel and bladder. Taken to ER. Had normal exam, normal CT of head, normal chemistries except potassium of 3.3 (nl >3.5).
On the 9th, I woke up with a post-nasal drip and a sore throat. The next morning, I had a slight fever and felt congested as my sore throat got worse. I took some Tylenol. I woke up from my nap and did an at-home test of COVID-19. The test came back positive, so I called my doctor's office and they prescribed me Afrin and told me to continue to take ibuprofen for the pain and to stay hydrated. I used the nasal spray 3 times a day and ate cough drops as well to help with my sore throat. After 2 or 3 days or so, I began feeling better.
slightly painful; 3 inch red circle where the injection was; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE ERYTHEMA (3 inch red circle where the injection was) and PAIN (slightly painful) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (3 inch red circle where the injection was) and PAIN (slightly painful). The patient was treated with CORTISOL ACETATE ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (3 inch red circle where the injection was) and PAIN (slightly painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; Immediate rash/welts about 2 inches above and 1 inch below and around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16May2021 at 09:15 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included lactose intolerance. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), fiber pills, and probiotic taken for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 09:15, the patient experienced immediate rash/welts about 2 inches above and 1 inch below and around the injection site. It happened within seconds of receiving the vaccine and was gone about 30 minutes later. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the event immediate rash/welts about 2 inches above and 1 inch below and around the injection site was recovered on 16May2021 at 09:45.  No follow-up attempts are needed. No further information is expected.
patient had loss of consciousness immediately following vaccination. Came to a few seconds later confused and dizzy, with low BP
Received Moderna booster on 12/8/21 Noticed hives on face, palms ear canals trunk and legs on 12/19/21.  Patient took zyrtec and benadryl and hives have dissipated. Says that bottom of her feet feel like she is stepping on hot coal.  When she takes the zyrtec and or benadryl she no longer has these issues.  She denies trouble breathing.  Denies use of new perfumes, lotion,new linens or towels,  soaps or hair dyes. Denies any diet changes, supplements, new medications or vitamins
This case was reported by a physician via other and described the occurrence of fatigue in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fatigue and discomfort. On an unknown date, the outcome of the fatigue and discomfort were recovered/resolved. The reporter considered the fatigue and discomfort to be probably related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. This case was reported by the patient's spouse. This case was reported by the physician assistant. The reporter did not specify when they received the dose. It was unknown if the events caused the patient to be admitted to the hospital overnight or prolong an existing hospitalization. It was unknown if the reporting health care professional consider the events to be life threatening. It was unknown if the reporting health care professional consider the events to result in persistent or significant disability or incapacity. The patient did not die. It was unknown if the events require surgical or medical intervention to prevent one of the outcomes described in preceding questions. The events did not result in a congenital anomaly or birth defect. This case is 1 of 4 cases reported by the same reporter.
Information has been received from a Nurse Practitioner, concerning a 16 year old female patient with no pertinent medical history or drug reactions/allergies, who on 19-JAN-2011 was vaccinated with a dose of GARDASIL (lot #666987/1016Z). There was no concomitant medication. On 20-JAN-2011 the patient experienced Raynaud's phenomenon with numbness, bluing, and slow capillary refill in both hands. The patient called the Nurse Practitioner for medical attention. There was no treatment given for the events. At the time of the report, the patient's outcome was unknown. Follow up information was received from the nurse practitioner concerning the female patient with no pre-existing allergies, birth defects or medical conditions and no illness at time of vaccination, who on 19-JAN-2011, at 3:45 pm, was vaccinated intramuscularly with the first dose of GARDASIL (lot#666987/1016Z). The nurse stated that on 20-JAN-2011 at 1:00 pm.  the patient's symptoms included numbness, tingling and blue coloration in both hands-fingers, finger stiff and sore, pale to blue not induced by temperature change. It also was reported that the patient never had these symptoms previously. The nurse reported as exam observations: fingers bilaterally pale with bluish hives on distal ends, slow capillary refill, not swelling and ulnar/radial pulse normally bilaterally. No other relevant diagnostic tests were reported. The adverse events required doctor visit. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Immediately after receiving her vaccination, she reported feeling lightheaded. She laid down on the floor. She was taken to a private section of the arena for monitoring. Her heart rate and blood pressure within normal limits. Her lightheadedness resolved within 15 minutes of monitoring.
Pain at shot side so that arm not usuable for 12 hrs, chills for a few hours, extreme fatigue (slept twice normal amount) mild headache
everything was going well until the same evening 4/4  9-10pm the chills started, fever, body aches, head ache and then extreme nausea.  I was violently sick to my stomach every hour on the hour until 9am the next day. I almost went to the hospital (probably should of) it was so bad and I was very scared, I called the 24/7 nurse line through my medical insurance around 1am 4/5. On 4/05 I was very tired slept all day and was vary dizzy.
mom called office 28APR98 w/sx of temp 102, listless, diarrhea;temp not dec p/vax APAP;pt adm to hosp, dx viral meningitis;
no adverse effects reported; the patient received first dose of VAQTA (lot number and expiration date unknown by reporter) on 1/7/2019. Medical Assistant reported the same patient received a second dose of VAQTA (R034339, expiration 11/23/2019) on 4/10/2019).; This spontaneous report was received from a medical assistant regarding an unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported.  On 07-JAN-2019, the patient received the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered for prophylaxis (route, dose, location of administration, lot # and expiration date were not reported). On 10-APR-2019, the patient received the second dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered for prophylaxis (route, dose and location of administration not reported) (lot # R034339, expiration date: 23-NOV-2019). No adverse events were reported.
Patient given Fluzone IM with 5/8" needle in LA per protocol.  As needle was removed; blood, exudate and vaccine poured frrom site.  Replacement dose given with 1" needle in RA without incident.
Arm soreness  - a little sore that evening and the next day it was swollen, hot, and painful. It got worse over that day. Maybe about 48 hours after the injection it hurt to move my arm at all and I couldn't put it over my head. The 3rd day it was still hot, painful. After three days it started getting better. About 10 days to 2 weeks later - I started having a headache. It was on the left side of my head. I have had a pretty low grade headache now for about two months. I have never had that before. It's almost like the muscle connecting from my shoulder to my head was injured in a way - although I hadn't injured it. As the pain the in the shoulder went away so did the headache. I also had a little lump - down below my collarbone and that lasted for about five days. I went in to see a  chiropractor (a week after the headache started - didn't help)  to see if he could help the headache go away; went again to chiropractor on March 4 and March 26th. I didn't seem to get any relief from the chiropractor visits. Then the headache finally went away last week.  I had the second dose on 3/3/2021 - I didn't have any additional adverse reactions (I did get really flu symptoms for less than 24 hours.) But the headache symptoms are the symptoms from the first dose that persisted. The headache lasted until March 23rd.
slight flu like symptoms; little reaction to the last one with a little swelling; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (slight flu like symptoms) and SWELLING (little reaction to the last one with a little swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (slight flu like symptoms) and SWELLING (little reaction to the last one with a little swelling). At the time of the report, INFLUENZA LIKE ILLNESS (slight flu like symptoms) and SWELLING (little reaction to the last one with a little swelling) outcome was unknown.            No concomitant was provided. No treatment was provided.   This case was linked to MOD-2021-281437 (Patient Link).
Information has been received from a licensed practical nurse concerning a 51 year old female patient who on 03-OCT-2007, was vaccinated into the left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (Lot# 659148/1382U). On 05-OCT-2007, the patient had an elevated temperature and enlarged lymph nodes. It was also reported that the patient had pneumonia at the time of vaccination. Subsequently, the patient recovered. This is one of two reports from the same source. Additional information has been requested.
approx 1wk p/vax pt devel shingles;the lesions started on lt scapula & shoulder area;they were resolving as of 4NOV97;
Confluent plaques and macules on entire body and face and groin Sand grains on inner cheeks and erythematous  throat
About 11AM began mild shaking then became limp & was taken to MD admitted to hosp for eval. temp found to be 103.
Approximately 5 minutes after receiving her covid vaccine, the patient was feeling unwell, dizzy, and lightheaded.  She then lost consciousness for 30-60 seconds.  The patient was assisted into a laying position on the floor and was provided with a pillow, ice packs, and a water bottle.  The patient continued to improve over the next 10 minutes and we allowed her to sit on the floor while leaning against a wall.  As she continued to improve, we allowed her to sit in a chair but asked that they stay in the pharmacy area a little longer for observation.  Within 5 minutes of this the patient lost consciousness again and did experience some muscle rigidity, which was short-lasting, and the patient was assisted to the ground and the same interventions taken.  The patient left in an ambulance out of an abundance of caution but required no further medical intervention.  The patient is at home and well per a phone conversation later in the evening.
Delayed period of over 18 days (cycle has ALWAYS been 25-27... NEVER 45 days!).
Client received dose of tetanus toxoid 10 days ago. Today is 42 days since first dose. Decision was made to administer dose of Moderna today as CDC cites tetanus as an example of a possible exception to the 10-day rule AND today is the last day of the current recommended maximum interval for the Moderna vaccine.
pt recvd vax & exp t106 & rash; PC to mom states that even w/regular doses of APAP fever elevated; seen by MD 27SEP94 & hospitalized; dx roseola; md may restrict pertussis w/ next immun;
first hurt bad; This case was reported by a consumer via (Faand described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient got the shingles vaccine and it hurt bad . For tolerance to 2nd dose, refer case US2021AMR175885.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR175885:Same reporter
This is a spontaneous report from a contactable Pharmacist via Pfizer sales representative. This Pharmacist  reported similar events for two patients. This is 1st of two reports. A male patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced localized redness and swelling that lasted a few days. Patient referred to Urgent Care and treated with diphenhydramine hydrochloride (BENADRYL).; Sender's Comments: Linked Report(s) : US-PFIZER INC-2017502092 same reporter/drug/event, different patients.
My blood sugar went to 364 and stayed there all day and then that night it was 267 and then it was the next morning 202 and then it went to normal in the low 100s. Hives in the crook of my right arm. Burning, itchy little red bumps. I couldn't swallow but I think that was from the high blood sugar as my mouth was very dry. I felt like I had a really bad cold, my head felt foggy.
It started with abdominal pain (like hunger pain). I sat down for dinner and took one bit and abdominal pain got worse. I felt like I was going to pass out. I started sweating and my vision was blurry, I had the shakes.  The sensation like your low sugar.  I was pale and my skin was sweaty .  After about 45minutes it cleared up.
after my first vaccine, I had a feeling of "euphoria" SUPER HUMAN and was able to complete very difficult  moves in the gym, which I was never able to complete for the past 6 years; I am still not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 54-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 16:45 (Lot number: EL3248) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Uterine Cancer" (unspecified if ongoing); "Bipolar 2" (unspecified if ongoing). Concomitant medication(s) included: OXYCARBAMAZEPINA; ALPRAZOLAM; QUETIAPINE; LORAZEPAM; AMPHETAMINE; VITAMINS D3; BIOTIN.The following information was reported: EUPHORIC MOOD (non-serious) with onset 24Mar2021, outcome "unknown", described as "after my first vaccine, I had a feeling of "euphoria" SUPER HUMAN and was able to complete very difficult  moves in the gym, which I was never able to complete for the past 6 years"; MALAISE (non-serious) with onset 2021, outcome "not recovered", described as "I am still not feeling well". Therapeutic measures were not taken as a result of malaise and EUPHORIC MOOD.Additional Information: After her first vaccine, she had a feeling of euphoria SUPERHUMAN and was able to complete very difficult  moves in the gym, which she was never able to complete for the past 6 years. This first vaccine event was not reported because it was a positive event and not an adverse event, but now she wondered if there is a connection between my reactions to both vaccines. Possibly an interaction with one of her concomitant medications. List of any other medications the patient received within 2 weeks of vaccination: Oxycarbaxepine, Alprazolam, Quetiapine, Lorazepam. Further prescriptions Amphetamine, Vitamins D3 and Biotin. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. It was reported that Awareness 1st dose of vaccine was on 03 March 2021 (Please note this was not reported at the time because the event was considered a positive effect) Only after the 2nd dose, was there potentially a connection between the two events. No follow-up attempts are possible. No further information is expected.
Fever started at 3:00pm. Nausea (2x vomiting) and diarrhea (until the evening of the following day). Fever broke after 4 hours. Headache and muscles aches persisted for 24 hours.
Left thigh erythema 19x21cm (max size) started in a few hours of injection warmth, tenderness, mild Blister about 2cm wide distal and medial to the site of injection, in the same thigh
Initial report was received on 05 November 2012 from a non health care professional. A neonate patient was exposed to DTAP (manufacturer, lot number, route, site and date of administration not reported) "five weeks ago" in utero. According to the reporter, the baby was born with "lockjaw" and now has a feeding tube. The patient is hospitalized. Information pertaining to the mother is captured in case 2012-10353. Documents held by sender: none.
Large red spots on back, chest, neck and both upper extremities. Benadryl given p.o.
experiencing incredible muscle pain and nerve pain; experiencing incredible muscle pain and nerve pain; cannot control her body temperature, sometimes it is high; Initial information received on 05-Mar-2020 regarding an unsolicited valid non-serious case received from a consumer/ non-health care professional.  This case involves a female patient of unknown age who was experiencing incredible muscle pain and nerve pain (neuralgia), (myalgia) and cannot control her body temperature, sometimes it is high (pyrexia), while she received vaccine DIPHTHERIA AND TETANUS TOXOIDS.  Medical history included Guillain-Barre syndrome (Gulliane Barre syndrome which was undiagnosed when she was 14 years old), Epstein Barr virus infection and difficult walking (Gait disturbance).   Past medical treatment(s), vaccination(s) and family history were not provided.  On 02-Mar-2020 on Monday, the patient received a dose of suspect DIPHTHERIA AND TETANUS TOXOIDS produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was experiencing incredible muscle pain and nerve pain (neuralgia), (myalgia) and cannot control her body temperature, sometimes it is high (pyrexia) (unknown latency) following the administration of DIPHTHERIA AND TETANUS TOXOIDS.  Laboratory data was not reported.  Final diagnosis was nerve pain, muscle pain and high temperature.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the patient had not recovered from nerve pain and muscle pain and outcome for cannot control her body temperature, sometimes it is high was unknown.  Information on the batch number was requested.
Patient's wife came into pharmacy stating that patient was having pain in the left arm where the shot was given. There is no redness nor bruising according to patient's wife however they complained of muscle pain still on 11/16/15.
Patient received the first dose of Moderna vaccine and became sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient received the first dose of Moderna vaccine and became sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Patient received the first dose of Moderna vaccine and became sick). At the time of the report, ILLNESS (Patient received the first dose of Moderna vaccine and became sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter called on behalf of their husband who received their first dose of Moderna vaccine on 05-Apr-2021 and became sick.   No Concomitant product use was reported  No treatment information was provided.